Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China
· Delayed Price · Currency is CNY 22.93
-0.34 (-1.46%)
Mar 9, 2026, 3:00 PM CST
SHA:688298 Revenue
In the year 2025, Zhejiang Orient Gene Biotech had annual revenue of 958.99M CNY with 15.83% growth. Zhejiang Orient Gene Biotech had revenue of 287.18M in the quarter ending December 31, 2025, with 68.63% growth.
Revenue
958.99M
Revenue Growth
+15.83%
P/S Ratio
4.62
Revenue / Employee
421.35K
Employees
2,434
Market Cap
4.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 958.99M | 131.08M | 15.83% |
| Dec 31, 2024 | 827.92M | 7.76M | 0.95% |
| Dec 31, 2023 | 820.16M | -7.95B | -90.65% |
| Dec 31, 2022 | 8.77B | -1.40B | -13.78% |
| Dec 31, 2021 | 10.17B | 6.90B | 211.43% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kinetic Medical | 1.02B |
| Nanjing Medlander Medical Technology | 431.59M |
| Medprin Regenerative Medical Technologies | 336.73M |
| Getein Biotech | 1.04B |
| Hangzhou AGS MedTech | 597.21M |
| Ningbo David Medical Device | 516.76M |
| Wuhan Easy Diagnosis Biomedicine | 351.25M |
| CareRay Digital Medical Technology | 320.53M |